SeqCenter is a sequencing service provider located in Pittsburgh, PA. We offer services on Illumina, PacBio, and Oxford Nanopore platforms. We are excited to launch our Illumina Protein Prep services at ASHG.
PhenX Toolkit
The PhenX (consensus measures for Phenotypes and eXposures) Toolkit is a web-based catalog of recommended measurement protocols of phenotypes and exposures suitable for inclusion in genomic, clinical, and translational research studies with human participants.
Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural aberrations. | Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. With real-time, multiomic nanopore sequencing, you can discover previously hidden human genomic, epigenomic, and transcriptomic variation — from the population to the single-cell level.
Novogene
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the world. | Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond. With state-of-the-art laboratories and operations across the United States, the United Kingdom, Germany, China, Thailand, Korea, Singapore, and Japan, Novogene has established a strong global presence to support scientific advancements worldwide. At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis. Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life. | Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing. | Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first-tier journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS)
NIAGADS is a designated national data repository for human genetics research that collaborates with researchers all over the world to facilitate data access and sharing for genomic and associated omics data related to Alzheimer’s Disease (AD) and Alzheimer’s Disease and Related Dementias (ADRD) as well as healthy aging. To date, NIAGADS offers >130 datasets, encompassing 211,000 samples, across >180,000 subjects and 23 data types. NIAGADS also serves as the data coordinating center for the Alzheimer’s Disease Sequencing Project (ADSP), supporting data production and analysis for this ongoing project that currently offers around 20,000 whole exomes and 58,000 whole genomes. In addition to qualified access data stored at NIAGADS, when possible NIAGADS makes AD/ADRD data accessible outside of the data access request process (in alignments with submitting institutional IRB guidance on appropriate sharing), through the NIAGADS Open Access platform, a suite of knowledgebases, data exploration modalities, and datasets available to the public. Supported by a talented and dedicated team of developers, data analysts, researchers, and project managers, NIAGADS is committed to helping their user base to identify datasets, access stored data, and share resulting data with the research community to advance the understanding of ADRD.
n6 Tec, Inc.
n6 is a pioneering genomics company rethinking how scientists prepare samples and generate data in the era of scaled sequencing. As the number of samples grows from thousands to millions, traditional workflows are too slow, too manual, and too variable. We’re here to change that. Our flagship platform, iconPCR™, is designed to simplify the most complex part of the sequencing workflow—without compromising quality. With our proprietary AutoNorm™ technology, we help researchers move seamlessly from amplification to quantification to normalization in a single step. The result: cleaner data, faster decisions, and fewer barriers to discovery. At n6, we combine deep technical expertise with a collaborative, scientist-first approach. We’re passionate about building tools that make genomics more accessible, scalable, and reliable—for every lab, everywhere.